Catalyst Pharmaceuticals Inc Strategic Asset Allocation Index

Latest as of March 2026: 2.7%

Catalyst Pharmaceuticals Inc strategic asset allocation index. Catalyst Pharmaceuticals Inc (CPRX) has a Strategic Asset Allocation Index of 2.7% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $27.29 Million) total $27.29 Million, measured against net assets of $1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Catalyst Pharmaceuticals Inc (CPRX) net asset quality to measure how much of total assets are equity-financed.

SAAI

2.7%
Strategic Assets / Net Assets

Strategic Assets

$27.29 Million
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$1.01 Billion
USD

Strategic Asset Allocation Index of Catalyst Pharmaceuticals Inc (2004–2025)

Strategic asset allocation index of Catalyst Pharmaceuticals Inc from 2004 to 2025. This chart shows how Catalyst Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the index stands at 2.7%, representing strategic assets of $27.29 Million against net assets of $1.01 Billion USD. Check Catalyst Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Catalyst Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2004–2025)

Catalyst Pharmaceuticals Inc strategic asset allocation index by year from 2004 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Catalyst Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Catalyst Pharmaceuticals Inc worth.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 2.4% $22.54 Million $- $22.54 Million $954.27 Million ▼ -0.6 pp
2024 3.0% $21.56 Million $- $21.56 Million $727.63 Million ▼ -1.3 pp
2023 4.3% $16.49 Million $- $16.49 Million $387.88 Million ▲ +4.0 pp
2022 0.3% $847.00K $847.00K $0.00 $300.42 Million ▼ -1.6 pp
2021 1.9% $3.98 Million $3.98 Million $- $206.83 Million ▲ +1.8 pp
2020 0.1% $129.80K $129.80K $- $169.60 Million ▼ -0.2 pp
2019 0.2% $210.47K $210.47K $0.00 $87.63 Million ▼ -10.1 pp
2018 10.3% $5.25 Million $245.43K $5.01 Million $50.78 Million ▲ +10.1 pp
2017 0.2% $191.38K $191.38K $- $80.96 Million ▼ -0.4 pp
2016 0.6% $244.20K $244.20K $- $39.31 Million ▲ +0.3 pp
2015 0.3% $191.55K $191.55K $- $55.48 Million ▲ +0.1 pp
2014 0.2% $71.38K $71.38K $- $35.24 Million ▲ +0.0 pp
2013 0.2% $40.63K $40.63K $- $21.39 Million ▼ -0.2 pp
2012 0.4% $53.68K $53.68K $- $14.62 Million ▲ +0.0 pp
2011 0.3% $12.19K $12.19K $- $3.76 Million ▼ -0.5 pp
2010 0.8% $45.00K $45.00K $- $5.52 Million ▼ -0.1 pp
2009 0.9% $68.00K $68.00K $- $7.62 Million ▼ 0.0 pp
2008 0.9% $96.00K $96.00K $- $10.56 Million ▲ +0.1 pp
2007 0.8% $128.00K $128.00K $- $16.32 Million ▲ +0.7 pp
2006 0.1% $20.00K $20.00K $- $19.85 Million ▼ -0.8 pp
2005 0.9% $4.00K $4.00K $- $446.46K ▲ +0.0 pp
2004 0.9% $1.00K $1.00K $- $117.58K —
pp = percentage points